President Commissioner PT Kalbe Farma, Boenyamin Setiawan received Lifetime Achievement Entrepreneur of The Year 2005

Boenjamin Setiawan, widely known as Dr. Boen, has an academic background in both pharmacology and pharmakinetics. He was awarded his PhD in pharmacology in 1961 in the USA. On his return to Indonesia he established a pharmaceutical business working from his own garage and partnering with his siblings who were also active in the medical field.
The success of the Kalbe Farma group under Dr. Boen's leadership has been founded on the local production of cheap generic ethical drugs to meet the economic and health needs of Indonesian people. The strategy is supplemented with alliances with overseas principles and a strong focus on research and development. New product lines have been steadily introduced and international markets developed in Asia and Africa. From very humble beginnings over 30 years ago, the Kalbe Farma group is now the largest pharmaceutical group in Indonesia with over 6000 employees. Around him, Dr. Boen has built a strong management team including his siblings and second generation.

He also enjoys the support and trust of the community, as can be seen from the many social, educational and civic organizations in which he holds key positions and responsibilities, past and present, most notably as Board Member of KOMNAS Lansia, Advisory Board Member of GP Farmasi, Advisory Board Member of KOMNAS Perempuan, Financial Advisor of Yayasan KEHATI, and Treasurer and one of the founders of Yayasan Pengembangan Kreativitas Indonesia. Despite his busy schedule overseeing the operations of the Kalbe Group, he finds time for community services through these organizations and remains active in the Faculty of Pharmacology of the University of Indonesia, where he passes his extensive knowledge in the pharmacology science to his students and colleagues.

Source
http://www.ey.com/GLOBAL/content.nsf/Indonesia/EoY_2005_-_Award_Recipients#Boenjamin_Setiawan

Great News for CAPD ASKES Users in Indonesia

Until now, patients with kidney failure can be managed with Hemodialysis, CAPD and kidney transplant. Among those 3 methods, CAPD (Continuous Ambulatory Peritoneal Dialysis) is currently a hot topic between Asian Nephrologists including Indonesia. This was expressed by Dr. Ginova Nainggolan, SpPD KGH in the Indonesia Nephrology Pre-congress Program on Thursday, November 24th, 2005 in Bali.

In the workshop, CAPD was discussed by speakers such as Prof. DR.Dr. Moch. Sja'bani, SppD KGH MSc, Dr. Tunggul D Situmorang SppD KGH and Prof. DR.Dr. Endang Susalit, SpPD KGH, Dr. Tommy Halauet, SpB.

Dr. Tunggul said, CAPD is very helpful in patients with kidney failure who have to undergo Hemodialysis. The advantage of CAPD is, the patients do not have to use the dialysis machine and may use it by themselves at home. Another advantages are they would have better physical conditions, may exercise as usual and their diet would not be as strict as when they are undergoing hemodialysis.

CAPD has been used in Indonesia since 1984, and according to Prof. Sja'bani at the moment, there are quite a lot of kidney failure patients in Indonesia, and most are from the 3rd class patients (poor people). The government is liable to manage the cost of CAPD through PT ASKES (goverment health assurance), especially for GAKIN (poor people).

In front of 150 participants, Dr. Ita Wijayanti from Kalbe Farma as a speaker explained the usage and function of instruments used in CAPD and the advantage of instruments produced by Baxter - Kalbe, one of them is the diminution of sepsis or peritonitis occurring.


Great News

There is a great news for CAPD Baxter – Kalbe Farma user or users to be, especially ASKES members:

• Free Starter Pack (this particular one has always been free)
• Free for Routine Pack 90 (formerly, participants have to pay Rp. 600.000)
• Only with an additional fee of Rp. 1.033.000 for Routine Pack 120 (a decrease from Rp. 1.600.000)
• The above regulations start October 2005.